Travere Therapeutics, Inc. (TVTX)

Travere Therapeutics Statistics

Total Valuation

TVTX has a market cap or net worth of $1.87 billion. The enterprise value is $1.95 billion.

Market Cap	1.87B
Enterprise Value	1.95B

Important Dates

The last earnings date was Thursday, May 1, 2025, after market close.

Earnings Date	May 1, 2025
Ex-Dividend Date	n/a

Share Statistics

TVTX has 88.80 million shares outstanding. The number of shares has increased by 6.78% in one year.

Current Share Class	88.80M
Shares Outstanding	88.80M
Shares Change (YoY)	+6.78%
Shares Change (QoQ)	+6.32%
Owned by Insiders (%)	0.90%
Owned by Institutions (%)	94.57%
Float	75.68M

Valuation Ratios

PE Ratio	n/a
Forward PE	121.00
PS Ratio	6.30
Forward PS	4.03
PB Ratio	57.05
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	7.13
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.05, with a Debt / Equity ratio of 12.20.

Current Ratio	2.05
Quick Ratio	1.97
Debt / Equity	12.20
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-20.03

Financial Efficiency

Return on equity (ROE) is -422.66% and return on invested capital (ROIC) is -30.87%.

Return on Equity (ROE)	-422.66%
Return on Assets (ROA)	-23.21%
Return on Invested Capital (ROIC)	-30.87%
Return on Capital Employed (ROCE)	-61.44%
Revenue Per Employee	$710,475
Profits Per Employee	-$588,857
Employee Count	385
Asset Turnover	0.45
Inventory Turnover	53.38

Taxes

Income Tax	-32,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +232.49% in the last 52 weeks. The beta is 0.88, so TVTX's price volatility has been lower than the market average.

Beta (5Y)	0.88
52-Week Price Change	+232.49%
50-Day Moving Average	18.47
200-Day Moving Average	16.94
Relative Strength Index (RSI)	61.64
Average Volume (20 Days)	1,598,471

Short Selling Information

The latest short interest is 10.64 million, so 11.98% of the outstanding shares have been sold short.

Short Interest	10.64M
Short Previous Month	11.05M
Short % of Shares Out	11.98%
Short % of Float	14.06%
Short Ratio (days to cover)	5.74

Income Statement

In the last 12 months, TVTX had revenue of $273.53 million and -$226.71 million in losses. Loss per share was -$2.78.

Revenue	273.53M
Gross Profit	47.65M
Operating Income	-225.09M
Pretax Income	-145.55M
Net Income	-226.71M
EBITDA	-178.61M
EBIT	-225.09M
Loss Per Share	-$2.78

Balance Sheet

The company has $322.24 million in cash and $400.46 million in debt, giving a net cash position of -$78.22 million or -$0.88 per share.

Cash & Cash Equivalents	322.24M
Total Debt	400.46M
Net Cash	-78.22M
Net Cash Per Share	-$0.88
Equity (Book Value)	32.82M
Book Value Per Share	0.37
Working Capital	191.71M

Cash Flow

Operating Cash Flow	-160.66M
Capital Expenditures	n/a
Free Cash Flow	-160.66M
FCF Per Share	-$1.81

Margins

Gross margin is 17.42%, with operating and profit margins of -82.29% and -82.88%.

Gross Margin	17.42%
Operating Margin	-82.29%
Pretax Margin	-82.60%
Profit Margin	-82.88%
EBITDA Margin	-65.30%
EBIT Margin	-82.29%
FCF Margin	n/a

Dividends & Yields

TVTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.78%
Shareholder Yield	-6.78%
Earnings Yield	-12.10%
FCF Yield	-8.58%

Analyst Forecast

The average price target for TVTX is $33.31, which is 58.02% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$33.31
Price Target Difference	58.02%
Analyst Consensus	Strong Buy
Analyst Count	14
Revenue Growth Forecast (5Y)	40.77%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TVTX has an Altman Z-Score of -2.92 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.92
Piotroski F-Score	4